Navigation Links
DrugNews: Pradaxa Study Reveals Stroke, Bleeding and Heart Attack Risks In Some Patients

New York, NY (PRWEB) September 17, 2013

The prescription drug resource center at is announcing updated information on the site for patients taking the blood thinner Pradaxa. A newly-released study shows patients with mechanical heart valves may face higher risks of stroke, bleeding and heart attacks*.

DrugNews was created to improve the safety of patients taking popular prescription drugs by providing the latest warnings, recalls, studies and legal news. Visitors can see if others are experiencing similar side effects and decide if they need legal advice.

Pradaxa is a blood thinner approved by the FDA in 2010 as a stroke preventative for patients with atrial fibrillation. Experts disagree, however, about its risks for internal bleeding. The FDA has advised Pradaxa is no more dangerous than traditional blood thinner warfarin**.

Others, like the Institute for Safe Medication Practices, have warned that patients may be nearly 5 times as likely to die from Pradaxa bleeding than from bleeding with warfarin***. A study this year from the Netherlands also suggests patients taking newer blood thinners like Pradaxa may be 55% more likely to suffer internal bleeding****.

Now, DrugNews has learned that researchers from Belgium reported a new study at the European Society of Cardiology which found patients with mechanical heart valves taking Pradaxa faced higher risks of stroke, valve blood clots, major bleeding and heart attacks than those taking warfarin*.

A growing number of patients have filed a Pradaxa lawsuit in the U.S. alleging internal bleeding, leading to the consolidation of cases in a special federal multidistrict litigation court. The case is formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois. The latest court records show as many as 1,389 cases filed.

Anyone affected by internal bleeding after taking Pradaxa is encouraged to visit or speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases, DrugNews only recommends lawyers who have already handled Pradaxa lawsuits.

Visit today for more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer.

*New England Journal of Medicine, 9/1/13;
**FDA, 11/2/12;
***Institute for Safe Medication Practices, 1/9/13;
****Gastroenterology, July 2013;

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugNews: Federal Court Moves Growing Mirena Lawsuits Forward
2. DrugNews: Latest Info Shows Rise in NuvaRing Lawsuits Alleging Blood Clots
3. Pradaxa Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Pradaxa Bleeding Litigation
4. Pradaxa Bleeding Lawsuits Help: Resource4thePeople Reports another Medical Research Study Finds Increased Bleeding Risks
5. Pradaxa Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Issuance of New Case Management Order in Federal Pradaxa Bleeding Litigation
6. Pradaxa Lawsuit News: Bernstein Liebhard LLP Comments on Study Findings Regarding Use of Pradaxa in Mechanical Heart Valve Patients
7. Pradaxa Bleeding Lawyers at Wright & Schulte LLC Note Growing Number of Filings in Federal Multidistrict Litigation Established for Pradaxa Lawsuits
8. Pradaxa Lawsuit News: Bernstein Liebhard LLP Comments on Boehringer Ingelheim’s Application to Expand Approved Uses for Pradaxa
9. Pradaxa Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Issuance of New Order in Federal Pradaxa Bleeding Litigation
10. Pradaxa Lawsuit Lawyers at Wright & Schulte LLC Disturbed by New Study Finding that Pradaxa Users Face Significantly Higher Risk of Bleeding Side-Effects
11. DrugRisk Update: Court Issues Latest Decision in Pradaxa Bleeding Litigation
Post Your Comments:
(Date:10/13/2015)... MA (PRWEB) , ... October 13, 2015 , ... Protein ... of the body, including muscle, bone, and blood. But how much protein does the ... complicated than it might seem, according to the October 2015 issue of Harvard ...
(Date:10/13/2015)... ... October 13, 2015 , ... T-System and Centegra ... than 59,000 emergency department visits per year, today announced the successful and rapid ... improve clinical, operational and financial outcomes. , In less than four ...
(Date:10/13/2015)... ... October 13, 2015 , ... World Patent Marketing , a vertically ... melting invention that helps people in clearing snow away from the streets and driveways. ... at 3.8% per year," says Scott Cooper, CEO and Creative Director of World Patent ...
(Date:10/13/2015)... ... October 13, 2015 , ... Thermi, ... the newest professional to introduce the latest development, ThermiVa® temperature controlled radiofrequency to ... leading professional in Obstetrics and Gynecology and a pioneer in the field of ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... and the Florida Apartment Association (FAA) has partnered with the Florida Department of ... the demand. , The FAA Smoke-Free Multifamily Housing Program launched last week ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)... WuXi PharmaTech (Cayman) Inc. (NYSE:  WX), a ... serving the pharmaceutical, biotechnology, and medical device industries, ... version of OncoWuXi, the first App in the ... and data on the go.  The OncoWuXi App ... to identify relevant tumor models for use in ...
(Date:10/13/2015)... Oct. 13, 2015  The Wyss Institute ... today announced the launch of its latest ... will introduce imaging reagents providing super-resolution capabilities ... of expensive specialized instruments. The announcement follows ... Office of Technology Development (OTD) and ...
(Date:10/13/2015)... -- --> --> Opportunities ... the Asthma and COPD Therapies market? Which areas are going ... new report shows you potential revenues to 2025, assessing data, ... 260 tables, charts, and graphs. Discover the most lucrative areas ... study lets you assess forecasted sales at overall world market ...
Breaking Medicine Technology: